Delayed Initiation of Olaparib Maintenance Therapy in Platinum Sensitive Recurrent Ovarian Cancer

NCT04377087 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

3

Enrollment

OTHER

Sponsor class

Stopped Slow enrollment

Conditions

Ovarian Cancer

Interventions

DRUG: Olaparib

Sponsor

Sarah E Taylor

Collaborators

[object Object]